Table 1. Breast cancer stages during (September/20–January/21) and prior to (September/19–January/20) the COVID-19 pandemic, according to the AJCC/UICC 8th edition TNM anatomic Staging System.
| Period | Stage I N (%) |
Stage II N (%) |
Stage III N (%) |
Stage IV N (%) |
p-valuea |
|---|---|---|---|---|---|
| September/19–January/20 (N = 457) |
94 (29.6%) |
198 (43.3%) |
106 (23.2%) |
59 (12.9%) |
<0.001 |
| September/20–January/21 (N = 268) |
25 (9.3%) |
101 (37.7%) |
100 (37.3%) |
42 (15.7%) |
a
Chi-squared test